Sanofi | Paris
Is Sanofi A Buy, Despite Recent Stumbles? | Entrepreneur
Sanofi Agrees to Pay $2.9 Billion For Provention Bio
Sanofi expanding Fabrazyme plant in MA
Inside Sanofi's General Medicines Unit: Embracing A New Commercial Model :: In Vivo
Sanofi runs new scholarship to boost diversity in healthcare
Expanding its pandemic influenza preparedness, Sanofi breaks ground on state-of-the-art facility in Pennsylvania | ROI-NJ
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal | Reuters
Sanofi launches Impact® brand of medicines for low-income countries
Sanofi begins moving into big Boston HQ
Exclusive: Sanofi to let go of staff at vaccine plants in India as part of review | Reuters
Sanofi pumps $750M into VC unit to push deeper into biotech investing | Fierce Biotech
Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA | Fierce Pharma
Sanofi vaccine mandate puts jobs in jeopardy | Eyewitness News
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Careers - Sanofi U.S.
Sanofi launches global health brand with non-profit treatments | Reuters
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too | Fierce Pharma
Sanofi to cut US price of its most-prescribed insulin by 78% | Reuters
Sanofi Bolsters Diabetes Position with $2.9B Provention Buyout | BioSpace
Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs | Fierce Biotech
